News

Medical Dialogues12h
Merck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billion
Bengaluru: Merck KGaA, a science and technology company, is in late-stage negotiations to buy SpringWorks Therapeutics, a US ...
Devdiscourse10h
Global Health Updates: From Mergers to Measles and Medicine
The latest health-related developments include Merck's acquisition talks with SpringWorks, disbandment of a US Justice ...
Devdiscourse18h
Global Health Headlines: Mergers, Outbreaks, and Judicial Decisions Shake the Sector
Recent health news highlights Germany's Merck's acquisition talks with SpringWorks, U.S. Justice Department's disbanding of a ...
pharmaphorum23h
Verily signs up four big pharmas to its clinical trials platform
Merck KGaA has confirmed that talks to buy SpringWorks have advanced to the 'late-stage' and are revolving around an offer of around $47 per share. The importance of biosimilars only continues to ...